Philomena Banner

Co-star Steve Coogan is also up for Oscar honors in the adapted screenplay category for his part in writing Philomena. Sources: Facebook, The Weinstein Company.

The Weinstein Company may be Hollywood's best when it comes to backing Oscar contenders that also boast commercial appeal, Fool contributor Tim Beyers says in the following video.

Just look at history. The studio's earlier "Best Picture" winners include The King's Speech and The Artist. This year, Philomena is up for the honor. Starring Judi Dench as a mother on a search for the son she was forced to give up in her youth, the film has a shot at four Oscars:

* Best Picture
* Best Actress (Judi Dench)
* Best Adapted Screenplay (Steve Coogan and Jeff Pope)
* Best Original Score

Financially, Philomena earned $51.6 million in overseas territories. Here in the U.S., 31.8% of the film's $33.1 million gross came after its nomination to the "Best Picture" list. All told, the film spent nearly 14 weeks in theaters. More than enough to turn a profit.

Philomena's tiny budget didn't hurt. The film's producers spent just $12 million to make the film. Figuring another $12 million for marketing and distribution puts box-office break-even at just $24 million vs. an estimated $42.4 million in receipts after payments to theaters. A win in any category would be gravy at this point.

But again, we've seen this from The Weinstein Company and its partners before. Last year, Silver Linings Playbook earned an estimated $38 million above production and marketing costs, and took home a Best Actress Oscar for Jennifer Lawrence in the process. The record may explain why Netflix (NASDAQ:NFLX) paid up for a streaming agreement with the Weinsteins, who called it the "biggest deal" in the studio's history.

Members should begin seeing first-run Weinstein Company releases in 2016, though a number of the studio's foreign titles are already available on Netflix. Philomena, which enjoyed backing from the BBC, should join the catalog soon enough.

Now it's your turn to weigh in. How do you rate Philomena's chances at the Oscars? Did you see the film? Please watch the video to get Tim's full take and then leave a comment to let us know where you stand, and whether you would buy, sell, or short Netflix stock at current prices.

The next step for you
Want to profit on business analysis like this? The key for your future is to turn business insights into portfolio gold through smart and steady investing ... starting right now. Those who wait on the sidelines are missing out on huge gains and putting their financial futures in jeopardy. The Motley Fool is offering a new special report, an essential guide to investing, which includes access to top stocks to buy now. Click here to get your copy today -- it's absolutely free.

Tim Beyers is a member of the Motley Fool Rule Breakers stock-picking team and the Motley Fool Supernova Odyssey I mission. He owned shares of Netflix at the time of publication. Check out Tim's web home and portfolio holdings or connect with him on Google+Tumblr, or Twitter, where he goes by @milehighfool. You can also get his insights delivered directly to your RSS reader.

The Motley Fool recommends Facebook and Netflix. The Motley Fool owns shares of Facebook and Netflix. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Compare Brokers